Latest bladder cancer Stories
Micromedic to continue developing its CellDetect® technology for monitoring the recurrence of bladder cancer TEL AVIV, Israel, July 1, 2014 /PRNewswire/ -- BioLight
Massive sequencing of cancer genomes brings to light new genes every day that could be involved in the process of tumour formation.
In light of Blue Cross and Blue Shield of Massachusetts’ recent Actos lawsuit, Flood Law Group announces it is investigating potential Actos claims. Washington,
SAN DIEGO, June 17, 2014 /PRNewswire/ -- Mirati Therapeutics, Inc.
A multi-center phase I study using an investigational drug for advanced bladder cancer patients who did not respond to other treatments has shown promising results in patients with certain tumor types.
The Firm is investigating Actos lawsuits on behalf of Type 2 diabetes patients who allegedly developed bladder cancer due to their use of the medication. New
DUNEDIN, New Zealand and HERSHEY, Pa., May 28, 2014 /PRNewswire/ -- Pacific Edge announced today that it has entered into a contractual agreement with MultiPlan, Inc.
AADi Initiates NIH Funded Clinical Trial for Patients with Bladder Cancer PACIFIC PALISADES, Calif., May 20, 2014 /PRNewswire/ -- AADi, LLC, a clinical stage biopharmaceutical company
Studies discuss physical activity, obesity, and hematuria evaluation across race and gender in bladder cancer mortality risk ORLANDO, Fla., May 17, 2014 /PRNewswire-USNewswire/ -- Aside from
The alleged link between Takeda’s Actos diabetes drug and bladder cancer continues to hear arguments in the nation’s courts amidst a backdrop of sanctions and chastisements over destroyed
- Monstrous in size or character; huge; prodigious; monstrously perverse, savage, cruel, etc.